Tag: Fool

Investing in the stock market can feel like navigating a jungle – thrilling but sometimes overwhelming.

However, there’s a trusty compass to help guide your way: strong cash flows. Companies with robust cash flows are like the steady heartbeats of the stock market, providing the lifeblood that fuels growth, innovation, and shareholder returns.

In this article, we’ll introduce you to two ASX shares with impressive cash flows, making them prime candidates for your investment portfolio today.

Whether you’re a seasoned investor or just starting, these cash flow champions are worth your attention. Let’s dive in and explore my two ASX stock picks below.

Super Retail Group Ltd (ASX: SUL)

Super Retail is a prominent retailing group in Australia and New Zealand, specialising in automotive, sports, and outdoor leisure products. The company operates several well-known brands, including Supercheap Auto, Rebel, BCF, and Macpac.

Established in 1972, Super Retail has grown significantly, offering a diverse range of products to meet the needs of enthusiasts and professionals alike.

The retailer generated cash flow from operations of $756 million over the last 12 months to December 2023. From here, the company paid for its capital expenditure of $155 million, which increased from $110 million in FY23 used to expand its store network in Supercheap Auto and Rebel in the main.

This leaves the company with a free cash flow of approximately $600 million, sufficient to cover its lease payment obligations of around $220 million.

Compared to its current market capitalisation of close to $3 billion, Super Retail offers a free cash flow yield of more than 13% even after considering the lease payments.

Goldman Sachs also recognised this potential investment opportunity. As my colleague James highlighted, Goldman Sachs included Super Retail as one of its top dividend shares to buy. The broker said:

We believe SUL will display resilience in a softer economic environment that is built upon its competitive advantage of high loyalty (~11.0m active members accounting for >75% of sales) and this will be further bolstered as the company launches the Rebel loyalty program and continues to build personalisation capabilities. Hence, we are Buy-rated on SUL.

The Super Retail share price has fallen almost 23% from its all-time high of $17.11 in February 2024.

NIB Holdings Limited (ASX: NHF)

NIB is an Australian health insurer that provides health and medical insurance products to Australian and New Zealand residents, as well as international students and workers.

Founded in 1952, NIB has expanded its services to include travel and life insurance. The company focuses on providing affordable and comprehensive coverage, leveraging digital platforms to enhance customer experience and accessibility.

For the last 12 months to December 2023, NIB generated a cash flow from operations of $304.4 million, which has increased over the previous five years from $180 million in FY18.

The company explained that policyholder growth across its businesses underscored its strong operating cash inflow. NIB Thrive and Midnight Health are growing at a healthy rate, more than offsetting a sluggish result from NIB Travel.

From the operating cash flow, the company paid for property and other capital expenditures of around $50 million, leaving approximately $250 million as a free cash flow.

Based on NIB’s current market price, its free cash flow represents around 7% of its current market capitalisation of $3.6 billion. This means that if you acquired the company as a whole today, it would generate about a 7% return in its cash flow, which isn’t too bad, in my view.

Goldman Sachs sees further upside in the NIB share price due to NIB’s policyholder growth, diversified earnings streams, and valuation appeal, as my colleague Zach summarised.

The NIB share price has dropped 14% over the last 12 months and is down just 0.4% year to date.

The post 2 ASX shares with strong cash flows appeared first on The Motley Fool Australia.

More reading

• Goldman Sachs says these 3 ASX dividend shares are buys
• Are these beaten-up ASX shares too cheap to ignore?
• 3 ASX stocks Warren Buffett could buy today
• Analysts name 3 ASX income stocks to buy now
• What are 3 of the safest ASX consumer discretionary shares in Australia right now?

Motley Fool contributor Kate Lee has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Super Retail Group. The Motley Fool Australia has positions in and has recommended Super Retail Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is taking a fall today.

Shares in the S&P/ASX 200 Index (ASX: XJO) biopharmaceutical company closed on Tuesday trading for $16.46.

Shares were frozen yesterday after the stock entered a trading halt pending additional details on the company’s proposed initial public offering (IPO) in the United States.

With those details now out, shares are swapping hands for $16.13 apiece at the time of writing, down 2.0%.

Here’s what ASX 200 investors are mulling over.

ASX 200 biotech stock pulls out of Nasdaq IPO

The Telix Pharmaceuticals share price is under pressure after the company announced that its Nasdaq listing is off the cards.

The US listing has been in the works since early January. In May, Telix Pharmaceuticals chair Kevin McCann said the dual listing would enable the ASX 200 biotech stock “to better access the deep pool of specialist investors focused on biotechnology and radiopharmaceuticals in the US”.

He added that the Nasdaq listing would give the company increased visibility which “will drive long-term value creation for shareholders”.

On 6 June, the company confirmed its intent to list American Depositary Shares (ADSs) on the Nasdaq. The Telix Pharmaceuticals share price hit record highs on the day.

Today the company said it opted to withdraw its proposed Nasdaq IPO at the terms provided under current market conditions, adding that the proposed discounts were not aligned with its duty to existing shareholders.

Telix said its plan to list on the Nasdaq wasn’t based on the need to raise capital. And since it first announced its intent to file on 4 January, the company has achieved a number of commercially significant milestones with its medical products. That’s seen the Telix Pharmaceuticals share price soar more than 70% since 4 January.

Commenting on the withdrawal from the Nasdaq IPO, Telix CEO Christian Behrenbruch said:

While this is not our desired outcome Telix’s strategic objectives must align with our duty to existing shareholders. I’d like to thank my team for the personal commitment and incredibly long hours put into this IPO process.

Telix Pharmaceuticals noted that its performance and prospects remain strong.

“As a profitable, cash generative company, Telix retains sufficient earnings and balance sheet capacity to deliver on its key corporate objectives,” the company stated.

Telix Pharmaceuticals share price snapshot

The Telix Pharmaceuticals share price is up 61% so far in 2024.

Long-term investors who bought shares five years ago will be sitting on eye-popping gains of 1,541%.

The post Telix Pharmaceuticals share price sinks on unexpected Nasdaq news appeared first on The Motley Fool Australia.

More reading

• Why this broker just upgraded Telix shares to a buy rating
• Why is the Telix Pharmaceuticals share price frozen today?
• 4 top ASX 200 stocks to buy now for the AI revolution
• 3 ASX 300 healthcare stocks ‘well positioned to outperform’
• 2 ASX biotech shares that could be the next Telix Pharmaceuticals

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Fortescue Ltd (ASX: FMG) shares have been known for huge dividend payouts in the last few years. The outlook for big dividends in the future is not strong, in my opinion.

The ASX iron ore share took full advantage of the elevated iron ore price in FY21, leading to an annual dividend per share of $3.58.

In FY22, the annual dividend per share was reduced to $2.07.

Can the Fortescue dividend recover to above $3 per share? I don’t think it will, for a few different reasons.

Increasing iron ore supply

The key factor enabling Fortescue to generate such a large profit and pay a big dividend in FY21 was the strong iron ore price.

Strong demand from China outstripped supply, leading to a higher commodity price.

I’m not sure the supply and demand equation will work as strongly as it did in Fortescue’s favour in the future.

The Chinese real estate sector is still struggling, so I don’t see this key iron ore user pushing up the iron ore price again like it did. India could be a big user of steel in the coming years, but it’s unlikely to be on the same scale as China.

On the supply side, a significant increase in iron ore mining could be a headwind for the iron ore price. In Africa, Rio Tinto Ltd (ASX: RIO) is part of the huge Simandou iron ore project, and Fortescue Ltd (ASX: FMG) is working on a project in Gabon.

Rio Tinto, Fortescue and BHP Group Ltd (ASX: BHP) all want to increase their production in Australia.

Lower dividend payout ratio

The Fortescue dividend payout ratio has been trending downwards, which means Fortescue is holding onto a larger proportion of its generated profit.

In FY21, Fortescue had a dividend payout ratio of 80%, which fell to 75% in FY22 and then 65% in both FY23 and the first half of FY24. A lower payout ratio obviously means smaller dividends for owners of Fortescue shares.

The business has an important reason to hold onto more of its cash – it has huge green energy ambitions related to green hydrogen, green ammonia, industrial batteries and more. It will need a lot of capital to realise its goals, even if it is successful at bringing on investment partners.

Even if Fortescue were making big enough profits to pay a $3 per share dividend, I don’t think it would be that generous with its dividend in the future because of the capital requirements.

Fortescue dividend projections

The estimate on Commsec for the Fortescue dividend per share in FY24 is $2.02, followed by $1.50 in FY25 and then sinking to $1.08 per share in FY26.

It’s possible the iron ore price may be stronger than expected in the medium term, as it was in FY21 and at the start of this year when it was above US$140 per tonne. But shareholders such as myself should be aware that the payout may not be as rewarding in the future.

The post Why the best dividend days may be over for Fortescue shares appeared first on The Motley Fool Australia.

More reading

• 2 top ASX 200 passive income stocks I’d buy now to boost my retirement
• Here’s the iron ore price forecast through to 2027
• If I buy 1,000 Fortescue shares, how much passive income will I receive?
• How to earn $1,900 in passive income with just $10,000 in savings
• Fortescue shares rally amid claims of green tech theft

Motley Fool contributor Tristan Harrison has positions in Fortescue. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Catapult Group International Ltd (ASX: CAT) has been a standout ASX All Ords stock in the last 12 months, surging 89% to $1.83 currently. This is an 81% advantage over the benchmark S&P/ASX 200 Index (ASX: XJO) in the past year.

It has also been all green for the stock since trading began in January – up 32% year to date.

Despite this impressive gain, many believe this ASX All Ords stock still has room to grow. Let me explain.

What’s driving this ASX All Ords stock?

Catapult’s growth has been driven by strong financial performance and strategic initiatives. For the financial year ending 31 March 2024, the ASX All Ords stock’s revenue reached a milestone of US$100 million, a 20% increase year over year.

This growth reflects the strength of its software as a service (SaaS) strategy, which has been pivotal in attracting new customers and increasing the annualised contract value (ACV).

Forager Funds Management has been optimistic about Catapult’s potential for a long time. In its latest report from May 2024, the firm noted that it hopes “…to be writing about Catapult for years to come. For many years, we have admired the opportunity ahead of this company.”

The fund manager highlighted the ASX All Ord stock’s well-known athlete tracking vests, which are used in various major sports leagues worldwide.

Any avid sports-watcher will be familiar with Catapult’s athlete tracking vests. You can see them through Pat Cummins’ whites on a summer day at the SCG or at a training session for every single NRL and AFL team in Australia.

Forager also praised Catapult’s strategic vision under CEO Will Lopes. “When appointed in 2021, CEO Will Lopes didn’t do much to change the perception that shareholders would never see potential translate to profits”, it said.

But three years later, it says Lopes was right, that Catapult “needed to spend more”, and “needed to spend first”. Forager believes he is the “right man” to do the job.

The share price has reacted positively to the past few results announcements from Catapult but we still think it is a long way short of the company’s true value.

What does Catapult’s future look like?

The company’s FY 2024 results were a standout, with Forager noting over 40% of the revenue growth “translated to incremental profit”.

“The growth should be similar in 2025 and management expects that incremental profitability to increase further”, it added.

For FY 2025, the ASX All Ords stock’s management said in the last earnings that it aims to sustain strong ACV growth and high retention rates.

The company plans to align with the Rule of 40 – a key valuation metric for SaaS companies – which combines revenue growth rate and profit margin. Catapult achieved a 43% rate last quarter, exceeding the 40% benchmark. It looks to maintain this next year.

Foolish takeaway: ASX All Ords stock with growth

Despite its substantial share price increase over the past year, this ASX All Ords stock’s strategic initiatives and financial performance suggest there is still considerable room for growth.

The company’s focus on technology, customer retention, and profitability positions it well for continued success. Investors will be watching closely to see how Catapult executes its plans in FY25 and beyond, making it a compelling ASX All Ords stock to keep on your radar.

The post Up 80% in a year, this ASX All Ords stock is a ‘long way short’ of its true value appeared first on The Motley Fool Australia.

More reading

• Why AVITA Medical, Catapult, Meridian Energy, and Telix shares are storming higher today
• Why Catapult, Clarity, Pro Medicus, and Qantas shares are rising today
• 3 ASX All Ords shares smashing new multi-year highs while the market sinks
• Catapult shines: 20% sales growth propels ASX tech stock to new 52-week high

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Catapult Group International. The Motley Fool Australia has recommended Catapult Group International. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The Nvidia (NASDAQ: NVDA) stock story keeps getting better, thanks primarily to the incredible demand for the company’s graphics processing units (GPUs) and related technology that enable artificial intelligence (AI) capabilities. It’s not too late to buy shares. Indeed, I just outlined 25 reasons to buy Nvidia stock now.

But there’s a key question worth addressing that doesn’t get much attention: When should you consider selling shares of Nvidia stock?

There are no “right” answers. Investors vary in terms of financial and personal factors. That said, below are three solid reasons for any investor to consider selling shares of Nvidia stock.

1. When CEO Jensen Huang no longer leads the company

Investors should consider selling at least some of their Nvidia shares when Huang no longer leads the company he co-founded in 1993. He reportedly turned 61 earlier this year and seems to love his work, so barring any health issues, he could be at Nvidia’s helm for a good number of years more. To say that Huang will be difficult to replace is an understatement.

Nvidia is many years ahead of the competition in AI-enabling technology thanks to Huang’s foresight. Starting more than a decade ago, he began to steadily use profits from Nvidia’s once-core computer gaming business to position the company to be in the catbird seat when the “AI Age” truly arrived. And arrive it did in late 2022, when generative AI made a big splash on the tech scene with OpenAI’s release of its ChatGPT chatbot. Generative AI greatly expands the potential applications for AI.

2. If and when the company’s GPUs seem to be losing their AI-enabling “gold standard” status

A more exact (but too long) subheading is the above plus the following tacked on: “And if the company fails to develop whatever tech is knocking its GPUs from their lofty position.”

Nvidia’s GPUs are by far the favored chips for speeding up the training of AI models and the running of AI applications in data centers. Estimates vary, but it’s widely projected that the company has more than a 90% share of the market for AI GPU chips for data centers, and more than an 80% share of the overall data center AI chip market.

This is a fantastic market to control. Advanced Micro Devices CEO Lisa Su projects that the global data center AI chip market will reach $400 billion in revenue by 2027, which would equate to a compound annual growth rate (CAGR) of more than 72% from its estimated size of $45 billion in 2023.

Nvidia’s data center business accounted for about 87% of its total revenue last quarter, and some greater (but unknown) percentage of its total profits. So, investors should consider selling shares if signs start pointing to the company’s tech being displaced as the gold standard for enabling AI processing in data centers.

How will we know? What signs will there be?

Other than staying abreast of the general space, there are two specific things investors can do. First, listen to Nvidia’s quarterly earnings calls. Besides being interesting, Huang and CFO Colette Kress are very forthright. Recordings of these calls are posted on Nvidia’s investor relations site, so you can listen at your leisure.

Second, monitor Nvidia’s margins — gross, operating, and profit, with special attention to gross margin. A company’s margins will steadily decline when it’s losing its competitive advantages. The key word is “steadily.” Occasional short-term declines or ups and downs aren’t usually reason for concern.

Below is Nvidia’s 10-year margin history. There are ups and downs, but the overall trend has been decisively up. This is a winner of a margin profile chart. (I used trailing-12-month margins for all three margin types because this smooths out some of the quarterly ups and downs. But you can also use quarterly data, as that might be easier.)

Data by YCharts. Gross margin = gross profit/revenue. Operating margin = operating income/revenue. Profit margin = net income/revenue. Gross profit, operating income, net income, and revenue can all be found on a company’s quarterly income statements.

3. To rebalance your investment portfolio

Nvidia stock has performed amazingly well over the long term, and particularly since 2023. So, in the last year and a half, it has no doubt grown to account for a much larger percentage of many investors’ total portfolios.

No matter how terrific a company, it’s risky to have too many of your eggs in one basket. That’s especially true with technology stocks, which tend to be inherently more volatile than stocks of companies in more stable industries.

So, it makes good sense for investors to regularly — perhaps, quarterly or annually — rebalance their portfolio so no single stock becomes too large a holding relative to their total investments. “Too large” is highly subjective, so you’ll have to decide what percentage range you’re comfortable with. 

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post Nvidia stock is still a great buy — but when should investors sell shares? appeared first on The Motley Fool Australia.

More reading

• Prediction: This will be Nvidia’s next big move
• Is Nvidia stock a buy after the 10-for-1 stock split?
• Will Apple stock be worth more than Nvidia by 2025?
• Is Nvidia going to $5 trillion after its 10-for-1 stock split?
• 4 top ASX 200 stocks to buy now for the AI revolution

Beth McKenna has positions in Nvidia. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Advanced Micro Devices and Nvidia. The Motley Fool Australia has recommended Advanced Micro Devices and Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If you are lucky enough to have $10,000 burning a hole in your pocket, then it could be worth putting it to work in the share market.

But would Woolworths Group Ltd (ASX: WOW) shares be a good option for these funds? Let’s see what an investment today could potentially turn into in one year.

Investing $10,000 into Woolworths shares

At present, the supermarket giant’s shares are changing hands for $32.50.

This means that if you were to invest $10,000 (and a further $10), you would end up owning 308 Woolworths shares.

Let’s now see what these shares could be worth this time next year.

According to a recent note out of Goldman Sachs, its analysts believe that now could be a great time to invest in the retailer.

In fact, your $10,000 investment could become worth significantly more if the broker is on the money with its recommendation.

It currently has a conviction buy rating and $39.40 price target on Woolies shares. If they were to rise to that level, those 308 units would have a market value of $12,135.20. That’s over $2,000 more than your original investment.

But wait, there’s more! Every six months, Woolworths shares a portion of its profits with shareholders in the form of dividends.

Goldman is expecting the company to pay fully franked dividends of $1.08 per share in FY 2024 and then $1.14 per share in FY 2025.

Let’s assume that this means dividends of $1.11 per share over the next 12 months (the final dividend of FY 2024 and the interim dividend of FY 2025). This would mean dividend income of $341.88 from those 308 shares.

In total, this brings the total return on investment to approximately $2,650.

Why invest?

Goldman believes that Woolworths shares are being undervalued by the market. Particularly given its It explains:

WOW is the largest supermarket chain in Australia with an additional presence in NZ, as well as selling general merchandise retail via Big W. We are Buy rated on the stock as we believe the business has among the highest consumer stickiness and loyalty among peers, and hence has strong ability to drive market share gains via its omni-channel advantage, as well as its ability to pass through any cost inflation to protect its margins, beyond market expectations. The stock is trading below its historical average (since 2018), and we see this as a value entry level for a high-quality and defensive stock.

The post How much could a $10,000 investment in Woolworths shares become in one year? appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Friday
• What is boosting the Treasury Wine share price on Thursday?
• Are Woolworths shares a bargain after falling 20%?
• If I buy 1,000 ANZ shares, how much passive income will I receive?
• Why QBE shares could deliver huge returns for investors that buy them today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If you’re wanting to build an income portfolio, then it could be worth considering the four ASX dividend stocks listed below.

Here’s why analysts think these buy-rated shares could be excellent options for income investors right now:

Coles Group Ltd (ASX: COL)

The first ASX dividend stock that could be a buy is Coles. It is of course a supermarket giant with over 800 stores across the country. In addition, it has a liquor network comprising almost 1,000 stores across several brands.

Morgans is a fan and has an add rating and $18.95 price target on its shares.

As for income, the broker is forecasting fully franked dividends of 66 cents per share in FY 2024 and 69 cents per share in FY 2025. Based on the current Coles share price of $17.01, this will mean dividend yields of 3.9% and 4.1%, respectively.

Telstra Group Ltd (ASX: TLS)

Goldman Sachs is feeling positive on this telco giant and sees it as an ASX dividend stock to buy. Particularly given the low risk earnings and dividend growth that is expected in the coming years.

The broker expects this to support the payment of fully franked dividends of 18 cents per share in FY 2024 and then 18.5 cents per share in FY 2025. Based on the current Telstra share price of $3.53, this equates to yields of 5.1% and 5.25%, respectively.

Goldman has a buy rating and $4.25 price target on Telstra’s shares.

Transurban Group (ASX: TCL)

Analysts at Citi think that Transurban could be an ASX dividend stock to buy. It is a leading toll road operator, building and operating toll roads in Australia and North America. Among its portfolio are CityLink in Melbourne and the Eastern Distributor in Sydney.

Citi currently has a buy rating and $15.50 price target on its shares.

It is expecting dividends per share of 63.6 cents in FY 2024 and then 65.1 cents in FY 2025. Based on the current Transurban share price of $12.55, this will mean yields of 5.1% and 5.2%, respectively.

Universal Store Holdings Ltd (ASX: UNI)

A final ASX dividend stock that could be a buy is Universal Store. It is the youth fashion retailer behind the Universal Store, Perfect Stranger, Thrills, and Worship brands.

Morgans is positive on the company, noting that “UNI’s focus on offering high quality, fashionable apparel in a well-presented store environment with high levels of service is paying off.”

The broker expects this to underpin fully franked dividends per share of 26 cents in FY 2024 and then 29 cents in FY 2025. Based on the current Universal Store share price of $5.00, this will mean yields of 5.2% and 5.8%, respectively.

Morgans has an add rating and $6.50 price target on its shares.

The post Why Telstra and these excellent ASX dividend stocks could be buys appeared first on The Motley Fool Australia.

More reading

• Buying Coles shares? Here are key metrics you’ll want to know
• Analysts name 3 small cap ASX shares to buy for big returns
• 3 lower-risk ASX shares for beginner investors
• Buy and hold these ASX dividend shares until 2034
• Overinvested in BHP shares? Here are two alternative ASX dividend stocks

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in Universal Store. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Transurban Group. The Motley Fool Australia has positions in and has recommended Coles Group and Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX 200 healthcare stock Neuren Pharmaceuticals Ltd (ASX: NEU) has posted impressive gains over the past year but one director appears to still see value in today’s share price.

Neuren shares closed the session on Thursday at $19.31, up 2.6% for the day. The ASX 200 healthcare stock outperformed the benchmark S&P/ASX 200 Index (ASX: XJO), which rose by 0.44%.

Over the past year, the Neuren Pharmaceuticals share price has risen 48.3% while the ASX 200 has lifted just 8.6%.

So, it’s interesting to see one of the company directors ploughing more of his own funds into the ASX 200 healthcare stock despite this impressive price lift.

Director invests almost $100,000 in Neuren shares

Neuren Pharmaceuticals issued a notice to the ASX yesterday advising that director Joseph Basile has increased his stake in the company by 50%.

Basile bought 5,000 Neuren shares on-market on Tuesday through his self-managed super fund (SMSF) for $19.49 apiece, for a total consideration of $97,450.

He already owned 10,000 Neuren shares, so the purchase lifted his stake in the ASX 200 healthcare stock by 50%.

What’s the latest news from this ASX 200 healthcare stock?

The last piece of price-sensitive news from Neuren came on 27 May when the company announced top-line results from the Phase 2 clinical trial of its second drug candidate, NNZ-2591.

The drug treats Pitt Hopkins syndrome (PTHS), which is a neurodevelopmental condition that causes developmental delays. It causes moderate to severe intellectual disability, hyperventilation and/or breath-holding while awake, seizures, gastrointestinal issues, speech difficulties, and sleep disturbances.

The top-line results showed a “statistically significant improvement” across all four efficacy measures.

Neuren Pharmaceuticals CEO Jon Pilcher said:

We are very excited about the results of this first clinical trial in Pitt Hopkins patients. This underserved community has such urgent unmet need and we can now continue towards our goal of developing a first approved treatment.

The ASX 200 healthcare stock rocketed 15.7% on the day of the news.

PTHS is caused by the loss of one copy, or a mutation, of the TCF4 gene on the 18th human chromosome. The incidence of PTHS is estimated at between 1 in 11,000 people and 1 in 41,000 people.

Neuren develops drugs for serious childhood neurological disorders that have no or limited approved treatments.

In the United States, all of its drugs have the designation of ‘orphan drug’. Biotechs working on orphan drugs are given special incentives, such as longer exclusive marketing rights, to ensure they make a profit.

Neuren also has an orphan drug designation for NNZ-2591 in Europe.

Neuren Pharmaceuticals share price snapshot

This ASX 200 healthcare stock has flown 1,565% higher over the past five years.

This compares to an 18.3% gain for the ASX 200.

The post This ASX 200 healthcare stock is up 48% in a year, but one director is still buying! appeared first on The Motley Fool Australia.

More reading

• These ASX shares could rise 25% to 35%
• Why Cettire, Neuren, Peter Warren, and Qantas shares are falling today
• Which ASX biotech shares are pioneering the future of medicine?
• This ASX 200 stock can rocket to a record high: Broker
• 5 things to watch on the ASX 200 on Tuesday

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Australian share market has historically provided investors with a return of approximately 10% per annum.

But that doesn’t mean that all ASX stocks rise by that level. Some will underperform and some will outperform the market.

And sometimes you will see shares that deliver mouth-watering returns that make the market return look minuscule.

The good news for investors with a high tolerance for risk is that analysts at Bell Potter see potential for one speculative ASX stock to do exactly this. In fact, they see scope for its shares to triple in value over the next 12 months.

Which ASX stock could rocket?

According to a note this morning, the broker believes that Meteoric Resources NL (ASX: MEI) shares could be extremely undervalued by the market.

In response to a revised resource estimate for the Capão do Mel (CDM) rare earths deposit at the Caldeira Project in Brazil, the broker has reaffirmed its speculative buy rating and 50 cents price target on its shares.

Based on its current share price of 16.5 cents, this implies that the ASX stock could rise 200% between now and this time next year.

What is the broker saying?

Bell Potter was pleased with the ASX mining stock’s resource estimate. It commented:

The M+I [measured and indicated] Resource at CDM defined 85Mt at 3,034ppm TREO, which included a high-grade core of 36Mt at 4,345ppm TREO using a 3,000ppm cut-off. Importantly, the high-grade zone we believe supports production over the first ~8 years (BPe). The scoping study, which was delayed until the release of the updated CDM Resource, is due for imminent release, and will be a major catalyst for the stock and broader ion adsorption/ ionic clay (IAC) projects. The updated resource for the entire Caldeira project increases to 619Mt at 2,538ppm TREO.

Its analysts then explain why they think investors should consider buying Meteoric Resources shares. The broker said:

We view the Caldeira project and MEI as being attractively positioned vs peers and maintain our valuation of $0.50/sh and Speculative Buy recommendation. We anticipate MEI will look to de-risk the project over the next 12 months, with the key catalyst being the release of the scoping study on its Southern projects. We currently estimate the market is factoring in less than the current depressed spot price for NdPr of ~US$50/kg, which differs significantly from our outlook of US$95/kg over the long term.

All in all, this could make it worth a closer look if you are wanting exposure to rare earths and have a high tolerance for risk.

The post Meet the speculative ASX stock that could rise 200% appeared first on The Motley Fool Australia.

More reading

• Small-cap expert reveals ASX mining stock with 150%+ upside

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Tesla (NASDAQ: TSLA) stock gained in Thursday’s daily trading session, with the electric vehicle (EV) innovator’s share price up almost 3% as of the close.

Tesla stock gained ground following indications that CEO Elon Musk’s latest compensation package is likely to be approved. After the market closed yesterday, Musk indicated that shareholders were poised to give the green light for a hotly contested pay package valued at roughly $56 billion. He also indicated that shareholders were voting in favor of moving the company’s place of incorporation from Delaware to Texas. Wall Street is apparently feeling bullish about both news items.

Musk’s big payday moves closer to reality, but there’s a catch

In 2018, Tesla board members approved a performance-based compensation package that would potentially award Musk with as much as $56 billion worth of company stock. But a Delaware judge struck down the pay package this January on the grounds that the company’s board had not shown that the compensation was fair or provided evidence that they had engaged in meaningful negotiations about the CEO’s pay. Shareholders have been voting on whether to reauthorize the deal.

While most of the votes on Musk’s pay package were submitted yesterday, a small remainder will be submitted later today. The pay package appears likely to pass, but some legal experts think that the Tesla CEO’s compensation will once again wind up being challenged in court.

What comes next for Musk and Tesla stock?

There’s no doubt that Musk’s leadership has been instrumental in Tesla’s incredible rise and stock performance. On the other hand, the EV company has been facing some significant challenges lately. Further complicating the question of Musk’s compensation, Tesla stock has seen big sell-offs this year despite an overall bullish backdrop that has powered explosive gains for many tech stocks.

TSLA data by YCharts

Valued at roughly 72 times this year’s expected earnings, Tesla continues to trade at highly growth-dependent multiples despite somewhat sluggish performance for the business. With the company facing pressure from the rise of Chinese EV makers and other players in the space, it may be hard to justify the company’s valuation when viewing it through the lens of a traditional automobile maker. But Musk has continued to invest heavily in innovation initiatives, and some investors are willing to assign a premium to the stock based on his vision and the company’s track record of disruption.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post Why Tesla stock jumped today appeared first on The Motley Fool Australia.

More reading

• Why Telstra and these excellent ASX dividend stocks could be buys
• This ASX 200 healthcare stock is up 48% in a year, but one director is still buying!
• Meet the speculative ASX stock that could rise 200%
• Sell these ASX 200 stocks now: Goldman Sachs
• Is the 11% dividend yield from Yancoal shares too good to be true?

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Tesla. Keith Noonan has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.